A
APYX
Apyx Medical Corporation
4.130
-0.120-2.82%After Hours: 3.960 -0.170 -4.12%18:32 05/22 EDT
OPEN/PREV CLOSE4.230/4.250
TODAY RANGE4.110-4.400
VOL127.49K
MARKET CAP172.94M
52 WEEK RANGE1.335-4.500
AVG VOL (3M)166.56K
% TURNOVER0.30%
TURNOVER--
P/E (TTM)-18.7302
% RANGE6.82%
EPS(TTM)-0.2205
P/E(FORWARD)-14.7500
P/B13.47
BVPS0.3065
DIVIDEND--
P/S3.266
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP146.68M
SHARES OUTSTANDING41.87M
NEXT EARNINGS08/05-08/10
FREE FLOAT35.52M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/14 12:28
Apyx Showcases Renuvion Study Highlighting Enhanced Liposuction Outcomes
Dow Jones·05/11 15:21
Apyx Medical Shares Rise After FDA Expands Clearance for AYON Liposuction Feature
TipRanks·05/11 12:31
Apyx Medical Gains FDA Clearance For Enhanced AYON System
Simply Wall St·05/11 10:28
Earnings Update: Here's Why Analysts Just Lifted Their Apyx Medical Corporation (NASDAQ:APYX) Price Target To US$6.50
TipRanks·05/09 00:46
Apyx Medical Rides AYON Surge in Latest Earnings
The Motley Fool·05/08 15:16
Apyx Medical (APYX) Q1 2026 Earnings Transcript
TipRanks·05/08 14:12
Apyx Medical (APYX) Gets a Buy from Craig-Hallum
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.